Chinese radiotherapy firm to buy former-NAS breast brachytherapy technology
This article was originally published in Clinica
Executive Summary
Huiheng Medical is to introduce the ClearPath breast brachytherapy system, a technology originally developed by the now bankrupt US company North American Scientific (NAS), to the Chinese market. The company also added that it looking to buy other technologies to launch in China.